Imidazoquinoline derivatives as adenosine A3 receptor ligands

Details Imidazoquinoline derivatives as adenosine A3 receptor ligands Imidazoquinoline derivatives as adenosine A3 receptor ligands

2005-05-16

2008-09-02

Anderson, Rebecca L (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S126000

Reexamination Certificate

active

07419977

ABSTRACT:
This invention is directed to a compound of formula (I),wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, Z, m, n, o, p and r are as defined herein, its preparation, pharmaceutical composition and use as an adenosine A3receptor ligand preferably an antagonist.

REFERENCES:
patent: 4291033 (1981-09-01), Barnes et al.
patent: 4333934 (1982-06-01), Barnes et al.
patent: 4474784 (1984-10-01), Barnes et al.
patent: 4644002 (1987-02-01), Barnes et al.
patent: 6376521 (2002-04-01), Jacobson et al.
patent: 6407236 (2002-06-01), Baraldi et al.
patent: 6686343 (2004-02-01), Okamura et al.
patent: 2002/0094974 (2002-07-01), Castelhano et al.
patent: 2004/0186133 (2004-09-01), Aranyi et al.
patent: 2005/0070566 (2005-03-01), Aranyi et al.
patent: WO 03/053968 (2003-07-01), None
Ager, et al., Synthesis and oral antiallergic activity of carboxylic acids derived from imidazo[2,1-c][1,4]benzoxazines, imidazo[1,2-a]quinolines, imidazo[1,2-a]quinoxalines, imidazo[1,2-a]quinoxalinones, pyrrolo[1,2-a]quinoxalinones, pyrrolo[2,3-a]quinoxalinones, and imidazo[2,1-b]benzothiazoles , J. of Medicinal Chem.; 31; 6; 1988; pp. 1098-1115.

Affiliated with

Also associated with

Rating

Imidazoquinoline derivatives as adenosine A3 receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazoquinoline derivatives as adenosine A3 receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazoquinoline derivatives as adenosine A3 receptor ligands will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3982664